Clark Estates Inc’s AbbVie ABBV Stock Holding History

Clark Estates Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$7.66M	–	84
2022 Q2	$7.66M	Sell	50,000 -30,400	-38%	-$4.65M	1.33%	21
2022 Q1	$13M	Sell	80,400 -26,900	-25%	-$3.91M	2.06%	15
2021 Q4	$14.5M	Hold	107,300	–	–	2.13%	13
2021 Q3	$11.6M	Hold	107,300	–	–	1.65%	16
2021 Q2	$12.1M	Hold	107,300	–	–	1.58%	16
2021 Q1	$11.6M	Buy	107,300 +3,900	+4%	+$417K	1.48%	18
2020 Q4	$11.1M	Buy	103,400 +15,500	+18%	+$1.49M	1.56%	19
2020 Q3	$7.7M	Buy	87,900 +21,500	+32%	+$2.02M	1.26%	22
2020 Q2	$6.52M	Buy	66,400 +18,400	+38%	+$1.62M	1.14%	24
2020 Q1	$3.66M	Hold	48,000	–	–	0.74%	31
2019 Q4	$4.25M	Hold	48,000	–	–	0.65%	34
2019 Q3	$3.63M	Hold	48,000	–	–	0.6%	42
2019 Q2	$3.49M	Buy	+48,000	New	+$3.77M	0.56%	53

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clark Estates Inc's ABBV Position: Q3 2022 in Review

Clark Estates Inc sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 50,000 shares — an estimated $7.66M sold.

Clark Estates Inc first reported a position in ABBV in Q2 2019 and held it in 13 quarters. The position peaked at $14.5M in Q4 2021. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Clark Estates Inc reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
Clark Estates Inc sold 50,000 AbbVie shares in Q3 2022, an estimated $7.66M.
Clark Estates Inc first reported a position in AbbVie in Q2 2019 and held it in 13 quarters.
Clark Estates Inc's AbbVie position peaked at $14.5M in Q4 2021.
2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Clark Estates Inc's 13F filing for Q3 2022, filed 14 Nov 2022.